Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 5, 2008, Pages 1479-1486

  Sun, Qiquan ^a   Liu, Zhihong ^a   Chen, Jinsong ^a   Chen, Huiping ^a   Wen, Jiqiu ^a   Cheng, Dongrui ^a   Li, Leishi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-ENDOTHELIAL CELL ANTIBODY; AUTOANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; ENDOTHELIAL CELL ANTIBODY; HLA ANTIGEN; PEPTIDE FRAGMENT;

ACUTE DISEASE; ADULT; ALLOTRANSPLANTATION; ARTICLE; BLOOD; CADAVER; CAPILLARY; ENDOTHELIUM CELL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AUTOANTIBODIES; CADAVER; CAPILLARIES; COMPLEMENT C4B; ENDOTHELIAL CELLS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RETROSPECTIVE STUDIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 53749089014     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04451007     Document Type: Article

References (25)

1. Pober JS, Orosz CG, Rose ML, Savage CO: Can graft endothelial cells initiate a host anti-graft : immune response? Transplantation 61: 343-349, 1996
2. Meroni PL, Del Papa ND, Raschi E, Tincani A, Balestrieri G, Youinou P: Antiendothelial cell antibodies (AECA): From a laboratory curiosity to another useful autoantibody. In: The Decade of Autoimmunity, edited by Shoenfeld Y, Amsterdam, Elsevier Science BV, 1999, pp 285-294
3. Youinou P: New target antigens for antiendothelial cell antibodies. Immunobiology 210: 789-797, 2005
4. Kallenberg CGN, Tervaert JW: Systerrak vasculitis. In: The Molecular Pathology of Autoimmune Diseases, edited by Theofilopoulos AN, New York, Taylor & Francis, 2002, pp 483-505
5. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J: The vascular endothelial cell antigen system. Transplantation 39: 286-289, 1985
6. Paul LC, Baldwin WM 3rd, van Es LA: Vascular endothelial alloantigens in renal transplantation. Transplantation 40: 117-123, 1985
7. Rose ML: Role of MHC and non-MHC alloantibodies in graft rejection. Curr Opin Organ Transplant 9: 16-22, 2004
8. Jordan SC, Yap HK, Sakai RS, Alfonso P, Fitchman M: Hyperacute allograft rejection mediated by anti-vascular endothelial cell antibodies with a negative monocyte crossmatch. Transplantation 46: 585-587, 1988
9. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E: Hyperacute rejection of two consecutive renal allografts and early loss of third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 5: 321-327, 1997
10. Perrey C, Brenchley PE, Johnson RW, Martin S: An association between antibodies specific for endothelial cells and renal transplant failure. Transpl Immunol 6: 101-106, 1998
11. Ferry BL, Welsh KI, Dunn MJ, Law D, Proctor J, Chapel H, Yacoub MH, Rose ML: Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection. Transpl Immunol 5: 17-24, 1997
12. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria: An addition to the Banff '97 Classification of Renal Allograft Rejection. Am J Transplant 3: 708-714, 2003
13. Sun Q, Liu Z, Yin G, Chen H, Chen J, Li L: Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation 79: 1759-1762, 2005
14. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al.: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999
15. Sun Q, Liu ZH, Yin G, Chen H, Chen J, Ji S, Li LS: Tacrolimus combined with mycophenolate mofetil can effectively reverse C4d-positive steroid-resistant acute rejection in Chinese renal allograft recipients. Nephrol Dial Transplant 21: 510-517, 2006
16. Sun Q, Liu ZH, Cheng Z, Chen J, Ji S, Zeng C, Li LS: Treatment of early mixed cellular and humoral renal allograft rejection with tacrolimus and mycophenolate mofetil. Kidney Int 71: 24-30, 2007
17. Sun Q, Liu ZH, Ji S, Chen J, Tang Z, Zeng C, Zheng C, Li LS: Late and early C4d-positive acute rejection: Different clinico-histopathological subentities in renal transplantation. Kidney Int 70: 377-383, 2006
18. Nakagawa Y, Saito K, Morioka T, Tomita Y, Takahashi K, Oite T: The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant 16[Suppl 8]: 51-57, 2002
19. Meehan SM, Domer P, Josephson M, Donoghue M, Sadhu A, Ho LT, Aronson AJ, Thisttethwaite JR, Haas M: The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol 32: 205-215, 2001
20. Gartner V, Eigentler TK, Viebalm R: Plasma cell-rich rejection processes in renal transplantation: Morphology and prognostic relevance. Transplantation 81: 986-991, 2006
21. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL: National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 4: 1033-1041, 2004
22. Le Bas-Bernatdet S, Hourmant M, Coupel S, Bignon JD, Soulillou JP, Charreau B: Non-HLA-type endothelial cell reactive alloantibodies in pre-transplant sera of kidney recipients trigger apoptosis. Am J Transplant 3: 167-177, 2003
23. Dragun D, Müller DN, Bräsen JH, Fritsche L, Nieminen-Kelhä M, Dechend R, Kintscher U, Rudolph B, Hoebeke J, Eckert D, Mazak I, Plehm R, Schönemann C, Unger T, Budde K, Neumayer HH, Luft FC, Wallukat G: Angiotensin II type 1-receptor-activating antibodies in renal-allograft rejection. N Engl J Med 352: 558-569, 2005
24. Zou Y, Stastny P, Süsal C, Döhler B, Opelz G: Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 357: 1293-1300, 2007
25. Pei R, Wang G, Tarsitani C, Rojo S, Chen T, Takemura S, Liu A, Lee J: Simultaneous HLA class I and class II antibodies screening with flow cytometry. Hum Immunol 59: 313-322, 1998